Home » Newsletters » BioWorld Science

BioWorld Science

July 3, 2014

View Archived Issues

Merz signs agreement with Brickell Biotech for novel retinoid therapy

China's regulatory authority approves phase II trials of F-351

Transcept Pharmaceuticals and Paratek Pharmaceuticals to merge

Pharmacodynamic effects of AZD-3241 revealed in PD patients

Osteogenesis improved in patients with hypophosphatasia

Johnson & Johnson completes divestiture of Ortho-Clinical Diagnostics

FOXO1 as a potential therapeutic target for diabetes demonstrated with AS-1842856

Vertex Pharmaceuticals discloses new ATR inhibitors for cancer

New CB2 receptor agonists patented by Roche

Allergan obtains FDA approval for Ozurdex and updates progress of key programs

Roche designs new SCD inhibitors for cancer

Agenus reports final results from phase II study of Prophage in newly diagnosed GBM

Rigel Pharmaceuticals divulges novel PKC inhibitors for ocular disorders

Researchers in the U.S. and China disclose new agents for cancer and other disorders

Genocea discloses 12-month follow-up data from phase I/IIa trial of HSV vaccine

Boston Strategics forms licensing deal with Eisai for E-6201

Scientists at Pierre Fabre design novel NMDA receptor antagonists

Synageva BioPharma reports topline data from phase III study of sebelipase alfa

Phase I first-in-human study begins for GLPG-1690

Insys Therapeutics receives FDA orphan drug designation for CBD

Genentech to acquire Seragon Pharmaceuticals

Oncoceutics presents preclinical data on lead compound

FDA grants priority review to nintedanib NDA for IPF

Taiho Pharmaceutical seeks additional indication approval in Japan for Zosyn

Rifaximin achieves endpoint in phase III trial in IBS with diarrhea

Boehringer Ingelheim files MAAs for tiotropium/olodaterol combination in Europe

Actavis completes Furiex acquisition

Pozen resubmits aspirin/omeprazole NDAs to the FDA

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...